Biotech CEO sentenced for $28M COVID-19 securities fraud
By SDCN Editor The CEO of a California biotechnology company was sentenced to seven years in prison for a securities fraud scheme that resulted in approximately $28 million in investor losses and obstruction of a related U.S....
Read More